BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 25724123)

  • 41. A systematic review regarding the prevalence of malignancy in patients with the hyper-IgE syndrome.
    Mohammadi T; Azizi G; Rafiemanesh H; Farahani P; Nirouei M; Tavakol M
    Clin Exp Med; 2023 Dec; 23(8):4835-4859. PubMed ID: 37924455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful interferon-alpha 2b therapy for unremitting warts in a patient with DOCK8 deficiency.
    Al-Zahrani D; Raddadi A; Massaad M; Keles S; Jabara HH; Chatila TA; Geha R
    Clin Immunol; 2014 Jul; 153(1):104-108. PubMed ID: 24743019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Confirmation of Hyperimmunoglobulin E Syndrome in Two Patients with an Ocular Problem: Detection of Two New DOCK8 Mutations.
    Saghafi S; Zandieh F; Fazlollahi MR; Glocker C; Frede N; Buchta M; Yang L; Mahmoudi AH; Houshmand M; Pourpak Z; Grimbacher B; Moin M
    Iran J Allergy Asthma Immunol; 2022 Jun; 21(3):355-363. PubMed ID: 35822685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical features, STAT3 gene mutations and Th17 cell analysis in nine children with hyper-IgE syndrome in mainland China.
    Zhang LY; Tian W; Shu L; Jiang LP; Zhan YZ; Liu W; Zhao XD; Cui YX; Tang XM; Wang M; Wu DQ; Yang XQ
    Scand J Immunol; 2013 Sep; 78(3):258-65. PubMed ID: 23659370
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Grave aortic aneurysmal dilatation in DOCK8 deficiency.
    Al Mutairi M; Al-Mousa H; AlSaud B; Hawwari A; AlJoufan M; AlWesaibi A; AlHalees Z; Al-Mayouf SM
    Mod Rheumatol; 2014 Jul; 24(4):690-3. PubMed ID: 24517560
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel DOCK8 gene mutations lead to absence of protein expression in patients with hyper-IgE syndrome.
    Qin T; An Y; Liu C; Wu J; Dai R; Liu D; Li X; Jiang L; Wu D; Tang X; Song W; Wang T; Zhao X
    Immunol Res; 2016 Feb; 64(1):260-71. PubMed ID: 26659092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation.
    Siegel AM; Stone KD; Cruse G; Lawrence MG; Olivera A; Jung MY; Barber JS; Freeman AF; Holland SM; O'Brien M; Jones N; Nelson CG; Wisch LB; Kong HH; Desai A; Farber O; Gilfillan AM; Rivera J; Milner JD
    J Allergy Clin Immunol; 2013 Dec; 132(6):1388-96. PubMed ID: 24184145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atypical Localization of Eczema Discriminates DOCK8 or STAT3 Deficiencies from Atopic Dermatitis.
    Kasap N; Kara A; Celik V; Bilgic Eltan S; Akay Haci I; Kose H; Aygun A; Akkelle E; Yakici N; Guner SN; Reisli I; Keles S; Cekic S; Kilic SS; Karaca NE; Gulez N; Genel F; Ozen A; Yucelten AD; Karakoc-Aydiner E; Schmitz-Abe K; Baris S
    J Clin Immunol; 2023 Nov; 43(8):1882-1890. PubMed ID: 37507632
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ILC3 deficiency and generalized ILC abnormalities in DOCK8-deficient patients.
    Eken A; Cansever M; Okus FZ; Erdem S; Nain E; Azizoglu ZB; Haliloglu Y; Karakukcu M; Ozcan A; Devecioglu O; Aksu G; Arikan Ayyildiz Z; Topal E; Karakoc Aydiner E; Kiykim A; Metin A; Cipe F; Kaya A; Artac H; Reisli I; Guner SN; Uygun V; Karasu G; Dönmez Altuntas H; Canatan H; Oukka M; Ozen A; Chatila TA; Keles S; Baris S; Unal E; Patiroglu T
    Allergy; 2020 Apr; 75(4):921-932. PubMed ID: 31596517
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Whole Genome Sequencing Reveals a Chromosome 9p Deletion Causing DOCK8 Deficiency in an Adult Diagnosed with Hyper IgE Syndrome Who Developed Progressive Multifocal Leukoencephalopathy.
    Day-Williams AG; Sun C; Jelcic I; McLaughlin H; Harris T; Martin R; Carulli JP
    J Clin Immunol; 2015 Jan; 35(1):92-6. PubMed ID: 25388448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical, immunological and molecular profiles of DOCK8 deficiency in six patients from a tertiary care centre in North India.
    Kumar Jindal A; Sil A; Aggarwal R; Tyagi R; Mondal S; Singh A; Barman P; Chawla S; Loganathan SK; Gupta K; Vinay K; Mahajan R; Saikia B; Kaur G; Sharma R; Saka R; Bhatia A; Sankhyan N; Pandiarajan V; Pilania R; Dhaliwal M; Sharma S; Vyas S; Suri D; Rawat A; Singh S
    Clin Exp Dermatol; 2024 Feb; 49(3):226-234. PubMed ID: 37815217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An update on the hyper-IgE syndromes.
    Yong PF; Freeman AF; Engelhardt KR; Holland S; Puck JM; Grimbacher B
    Arthritis Res Ther; 2012 Nov; 14(6):228. PubMed ID: 23210525
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey.
    Chandesris MO; Melki I; Natividad A; Puel A; Fieschi C; Yun L; Thumerelle C; Oksenhendler E; Boutboul D; Thomas C; Hoarau C; Lebranchu Y; Stephan JL; Cazorla C; Aladjidi N; Micheau M; Tron F; Baruchel A; Barlogis V; Palenzuela G; Mathey C; Dominique S; Body G; Munzer M; Fouyssac F; Jaussaud R; Bader-Meunier B; Mahlaoui N; Blanche S; Debré M; Le Bourgeois M; Gandemer V; Lambert N; Grandin V; Ndaga S; Jacques C; Harre C; Forveille M; Alyanakian MA; Durandy A; Bodemer C; Suarez F; Hermine O; Lortholary O; Casanova JL; Fischer A; Picard C
    Medicine (Baltimore); 2012 Jul; 91(4):e1-e19. PubMed ID: 22751495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyperimmunoglobulin E syndromes in pediatrics.
    Zhang Q; Su HC
    Curr Opin Pediatr; 2011 Dec; 23(6):653-8. PubMed ID: 21970826
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical, immunological features and follow up of 20 patients with dedicator of cytokinesis 8 (DOCK8) deficiency.
    Haskologlu S; Kostel Bal S; Islamoglu C; Aytekin C; Guner S; Sevinc S; Keles S; Kendirli T; Ceylaner S; Dogu F; Ikinciogullari A
    Pediatr Allergy Immunol; 2020 Jul; 31(5):515-527. PubMed ID: 32108967
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lineage-Specific Chimerism and Outcome After Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency.
    Raedler J; Magg T; Rohlfs M; Klein C; Vallée T; Hauck F; Albert MH
    J Clin Immunol; 2021 Oct; 41(7):1536-1548. PubMed ID: 34080085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DOCK8 deficiency: Insights into pathophysiology, clinical features and management.
    Biggs CM; Keles S; Chatila TA
    Clin Immunol; 2017 Aug; 181():75-82. PubMed ID: 28625885
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DOCK8 deficiency.
    Su HC; Jing H; Zhang Q
    Ann N Y Acad Sci; 2011 Dec; 1246():26-33. PubMed ID: 22236427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A case of partial dedicator of cytokinesis 8 deficiency with altered effector phenotype and impaired CD8⁺ and natural killer cell cytotoxicity.
    Ruiz-García R; Lermo-Rojo S; Martínez-Lostao L; Mancebo E; Mora-Díaz S; Paz-Artal E; Ruiz-Contreras J; Anel A; González-Granado LI; Allende LM
    J Allergy Clin Immunol; 2014 Jul; 134(1):218-21. PubMed ID: 24636087
    [No Abstract]   [Full Text] [Related]  

  • 60. DOCK8 deficiency with hypereosinophilia and the syndrome of inappropriate antidiuretic hormone secretion during herpes infection.
    Yeşil AM; Kayaoğlu B; Gül E; Gönç N; Özön A; Tezcan İ; Gürsel M; Çağdaş D
    Turk J Pediatr; 2023; 65(3):536-541. PubMed ID: 37395973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.